China's Ten Ministries Issue 15th Five-Year Plan for Pharmaceutical Industry
China's Ministry of Industry and Information Technology and nine other departments issued the 15th Five-Year Plan for the pharmaceutical industry on September 18, 2026. The plan calls for stronger original innovation capacity, focusing on major infectious diseases, major chronic diseases, rare diseases and pediatric medicines, and accelerating the upgrade of innovative drug and device research toward first-in-class, breakthrough and disruptive advances.
On September 18, 2026, the Ministry of Industry and Information Technology and nine other departments issued the 15th Five-Year Plan for the Development of the Pharmaceutical Industry.
The plan calls for strengthening original innovation capacity, focusing on key areas such as major infectious diseases, major chronic diseases, rare diseases and pediatric medicines, reinforcing the principal role of enterprises in innovation, and accelerating the upgrade of China's innovative drug and medical device research and development toward first-in-class, breakthrough and disruptive advances.
The plan also calls for supporting pharmaceutical enterprises in targeting frontier medical science and technology to develop a batch of first-in-class (FIC) drugs with new targets, new mechanisms and new drug types, as well as best-in-class (BIC) drugs, and to accelerate the research, development and application of a batch of frontier and leading high-end medical devices.
Why this event matters
The event has a measured impact on 5 industrys. The strongest current signal is positive for Biotechnology, with intensity 75/100 and 85% confidence over a medium term horizon.
Biotechnology
- Direction
- positive
- Intensity
- 75
- Confidence
- 85%
- Horizon
- Medium term
Pharmaceuticals
- Direction
- positive
- Intensity
- 72
- Confidence
- 85%
- Horizon
- Medium term
Medical Equipment
- Direction
- positive
- Intensity
- 70
- Confidence
- 82%
- Horizon
- Medium term
Pharmaceutical R&D Services
- Direction
- positive
- Intensity
- 65
- Confidence
- 75%
- Horizon
- Medium term
Pharmaceutical Chemicals
- Direction
- mixed
- Intensity
- 50
- Confidence
- 65%
- Horizon
- Medium term
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.